Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enterobacteriaceae Infections”

382 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 382 results

Post-approval studies (Phase 4)Looking for participantsNCT05979545
What this trial is testing

EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics

Who this might be right for
Blood Stream InfectionsVentilator Associated PneumoniaHealthcare Associated Infection+2 more
National University of Singapore 1,900
Not applicableStudy completedNCT02852902
What this trial is testing

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.

Who this might be right for
Clinically Significant BacteremiaOrgan TransplantationInfection+6 more
Spanish Network for Research in Infectious Diseases 820
Not applicableStudy completedNCT02140502
What this trial is testing

Incidence of Fluoroquinolone Resistant Bacteria in Patients Undergoing Prostate Biopsy

Who this might be right for
Fluoroquinolone Resistant Enteric Bacteria
Helsinki University Central Hospital 200
Testing effectiveness (Phase 2)Study completedNCT01193907
What this trial is testing

Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old)

Who this might be right for
Typhoid Fever
Novartis 88
Not applicableStudy completedNCT02947295
What this trial is testing

Global Genomic and Proteomic Profiling of African Children With Typhoid Fever

Who this might be right for
Typhoid Fever
University of Nebraska 969
Large-scale testing (Phase 3)Ended earlyNCT04876430
What this trial is testing

Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae InfectionBloodstream Infection
Hospital de Clinicas de Porto Alegre 13
Testing effectiveness (Phase 2)Looking for participantsNCT07049159
What this trial is testing

Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old

Who this might be right for
Shigella
Eveliqure Biotechnologies GmbH 72
Not applicableWithdrawnNCT03391674
What this trial is testing

Fecal Microbiota Transplantation for Eradication of Carbapenem-resistant Enterobacteriaceae Colonization

Who this might be right for
Antibiotic Resistant StrainMicrobial Colonization
Rambam Health Care Campus
Testing effectiveness (Phase 2)Study completedNCT01013259
What this trial is testing

Immunomodulation of E.Coli Nissle 1917 in Patients With Grass Pollen Rhinoconjunctivitis

Who this might be right for
Rhinoconjunctivitis
Charite University, Berlin, Germany 34
Early research (Phase 1)Study completedNCT00654108
What this trial is testing

Safety and Immunogenicity of Peru-15-pCTB in Healthy Adult Subjects

Who this might be right for
Gastroenteritis Escherichia Coli
National Institute of Allergy and Infectious Diseases (NIAID) 62
Not applicableStudy completedNCT05413772
What this trial is testing

Temocillin in ESBL-Enterobacteriaceae Infections

Who this might be right for
Infectious Disease
Assistance Publique - Hôpitaux de Paris 29
Not applicableStudy completedNCT03349814
What this trial is testing

Explanations for Negative Laparoscopic Appendectomies and Normal Laparoscopies

Who this might be right for
AppendicitisYersinia Enterocolitica InfectionYersinia Pseudotuberculosis Infections+1 more
Herlev Hospital 225
Early research (Phase 1)Ended earlyNCT02922816
What this trial is testing

FMT for MDRO Colonization After Infection in Renal Transplant Recipients

Who this might be right for
Infection Due to Resistant Organism
Emory University 11
Testing effectiveness (Phase 2)Study completedNCT01080716
What this trial is testing

Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate

Who this might be right for
DysenteryShigellaDiarrhea
U.S. Army Medical Research and Development Command 30
Not applicableStudy completedNCT00167986
What this trial is testing

Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care

Who this might be right for
Escherichia Coli InfectionsKlebsiella Infections
Wyeth is now a wholly owned subsidiary of Pfizer 480
Not applicableStudy completedNCT05535751
What this trial is testing

Cefepime vs. Carbapenems for Treating AmpC β-lactamase-producing Enterobacteriaceae Bloodstream Infections

Who this might be right for
Bacteremia
University Hospital, Strasbourg, France 200
Large-scale testing (Phase 3)Temporarily pausedNCT03802461
What this trial is testing

Effectiveness of Fecal Flora Alteration for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization

Who this might be right for
Infection
Susy Hota 40
Not applicableStudy completedNCT01225042
What this trial is testing

The Effect of Probiotics on E. Coli Gastroenteritis

Who this might be right for
GastroenteritisBacterial InfectionDiarrhea
NIZO Food Research 40
Not applicableUnknownNCT04235361
What this trial is testing

Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRC

Who this might be right for
Ebola Virus DiseaseMalariaTyphoid Fever+3 more
University of Stirling 500
Early research (Phase 1)Study completedNCT03089879
What this trial is testing

Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or naïve Subjects Not Part of H03_01TP Study

Who this might be right for
Dysentery, Bacillary
GlaxoSmithKline 35
Next Page